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SUMMARY 
Olfactory Bulb Ensheathing Glia (OB-OEG) promote spinal cord injury (SCI) 
repair in rats after transplantation at acute or subacute stages (up to 45 days). However, 
the most realistic clinical scenario is the chronic, in which no more cellular and 
molecular changes take place at the injury, and this occurs beyond the third month in 
rodents.  Whether adult OB-OEG grafts promote repair of severe chronic SCI has not 
been previously addressed.  Rats with complete SCI that were transplanted 4 months 
after injury exhibited a progressive improvement in motor function and axonal 
regeneration from different brainstem nuclei across and beyond the SCI site. A positive 
correlation between motor outcome and axonal regeneration suggested a role for 
brainstem neurons in the recovery. Functional and histological outcomes did not differ 
after transplantation at subacute or chronic stages.  Thus, autologous transplantation is a 
feasible approach as there is a time-frame for patient stabilization and OEG preparation; 
moreover, the healing effects of OB-OEG on established injuries may offer new 
therapeutic opportunities for chronic SCI patients. 
 
Key words: axonal regeneration, chronic transplantation, paraplegia, glial scar, 
functional recovery. 
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INTRODUCTION 
Most spinal cord injuries (SCI) cause permanent and irreversible functional 
deficits in patients.  The devastating prognosis for people suffering severe SCI has 
provided an impetus to search for therapies aimed at curing this chronic pathology and 
olfactory ensheathing glia (OEG) transplantation is a promising repair strategy. There 
are more than 40 articles showing positive effects of OEG after SCI of various types 
and severities (reviewed in (1)), most after spinal cord trauma, (2-9) including contusion  
(10), but there are 13 articles showing no or limited beneficial effects. The differences 
seem related to the sources of cells, the ages of the animals and the methods used for 
culture and transplantation.  After the third week in vitro, adult rodent OB-OEG become 
senescent with an associated change in phenotype (11).  Thus, grafting of older cultures 
may compromise cell survival and/or migration (12-15).  Whether to use OEG from the 
olfactory bulb (central) or from the epithelium (peripheral) is also a debated issue.  
Mucosally derived OEG are more accessible, but they seem to have inferior migratory 
and growth-promoting properties (16-18) compared with bulbar OEG (2-9).  Based on 
these studies and the prospect for autologous therapy, we have used adult nonsenescent 
OEG of bulbar origin in this study. 
In most of the previous studies, OEG have been transplanted immediately after 
SCI (acute stage).  Because many patients take several weeks or even months for 
clinical stabilization, however, a delayed transplant paradigm would be more clinically 
relevant.  Moreover, if autologous transplantation is to be used, cell preparation requires 
time.  Hence, an intervention several months after SCI is a more realistic paradigm. 
Experimental OB-OEG grafting has been delayed for 7 and 30 days (10, 19) but never 
beyond 45 days (20); which has been considered to be the subacute stage (21, 22). SCI 
are considered to be at the chronic stage when, in the absence of further manipulation, 
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no more cellular and molecular changes occur, which is after the third month in rodents 
(21, 22).  Here, we determine the repair efficacy of OB-OEG grafted at the chronic 
stage into the injury site after complete SCI to evaluate real axonal regeneration rather 
than plasticity of spared fibers.  We also compared functional and histological outcomes 
with grafting at the subacute stage and quantified the regeneration of relevant 
descending motor tracts at both subacute and chronic stages. 
 
METHODS 
The experimental procedures adhered to the recommendations of the European 
Union and the US Department of Health for the care and use of laboratory animals and 
were approved by the Ethics Committee of our institution. 
 
OEG cultures from adult olfactory bulbs 
OB-OEG primary cultures were obtained from the first two olfactory bulb layers 
of 2- to 2.5- month-old Wistar Hannover rats (Harlan Laboratories, Barcelona, Spain). 
Seven days after plating, p75 receptor-expressing OB-OEG were purified as reported 
previously (2, 11).  They were cultured in D/F-10S (1:1 DEMEM:Ham’s F-12, Gibco-
Invitrogen, Madrid, Spain; 10% fetal bovine serum), at 37ºC, 5% CO2.  At 2 days after 
purification, 2 M forskolin (Sigma-Aldrich Química, Madrid, Spain) and 20 g/ml 
bovine pituitary extract (Biomedical Technologies Inc., Stoughton, MA) were added.  
Pure p75-OEG were expanded for less than 2 weeks to avoid senescence (11).  Cells 
were detached from the flasks, labeled with bisbenzimide (Hoechst 33342; Sigma) and 
transplanted at a density of 100,000 cells/μl in DMEM as performed previously (2, 4, 
23, 24). 
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Surgery and OB-OEG transplantation 
Twenty-eight adult female Wistar Hannover rats (2.5-3 months of age, 200-230 
grams, n=28) were anesthetized with isofluorane and N2:O2 (40:60) and a laminectomy 
to expose T8 to T9 segments performed. In 22 of the animals, the dura was opened and 
the spinal cords completely sectioned using microscissors.  The stumps were lifted to 
ensure completeness of the lesion (Fig. 1A) (4).  
The paraplegic animals were then divided into 3 groups: i) subacute (SA), ii) 
Chronic (Chr) and iii) Non-transplanted (Non-T).  The SA rats (n=5) were transplanted 
with p75 OB-OEG at 1 month after injury and Chr rats (n=5) at 4 months after SCI.  
Non-T animals (n=12) were not transplanted but injected with DMEM after 1 (n=6) and 
4 months (n=6). Six more animals were not transected (sham-operated group) and 
received a second surgery after 1 (n=3) and 4 months (n=3). In the second surgery, we 
removed the connective tissue formed underneath the resin bridge and above the spinal 
cord (Fig. 1D) to expose the injury region.  Glial and fibrous scars, created between the 
spinal cord stumps, were not removed (Fig. 1E).  The OB-OEG were stereotaxically 
grafted into both, caudal and rostral intact spinal cord stumps, at 1mm from the stump 
border, as previously described (4, 23) (Fig. 1F).  Cells were injected in the midline of 
each stump, from ventral to dorsal, into 4 sites at 1.3, 1.0, 0.8 and 0.5 mm respectively. 
Each site received 0.5 µl of 50,000 OEG (200,000 per stump). Non-T animals were 
injected with 0.5 µl of DMEM instead, and shams were not injected. 
In both surgeries, spinal cords were covered with durafilm (Ferrosan, London, 
UK). Vertebral columns were stabilized placing a resin bridge between adjacent 
vertebrae (Fig. 1C), made of an autopolymerizing acrylic resin (DuraLay; Reliance, 
Dental Manufacturing. Co. worth, IL) (25) (26). 
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Animal care, physiotherapy and rehabilitation 
Immediately after surgery, rats received 1 ml of Ringer´s lactate solution and 
analgesic magnesium metamizol (Nolotil, Boeringer Ingelheim, Barcelona, Spain) 
subcutaneously. An antibiotic, Augmentine (amoxiciline/clavulanic acid, 1g/200mg, 
GlaxoSmithKline, Madrid, Spain), was also administered and twice more every 8 hours. 
Urinary bladder was manually expressed 4 times a day until autonomous voidance and 
then once daily.  Detailed postoperative care has been described (27).  To keep 
paraplegic rats in good condition they received active and passive ROM (range of 
motion).  Active ROM was performed using the climbing test once a week (Appendix 
1).  Daily passive ROM included movement of joints below the level of injury (25 times 
each joint) and massages of muscles and skin over bone prominences. 
All animals were allowed to survive for 12 months after the first surgery (lesion 
surgery) and subjected to a third surgery for tracer injection (see below).  All  paraplegic 
animals with complete lesion had to be maintained in good and stable clinical condition 
for 1 year.  After paraplegia, animals had 2 additional surgeries, one for OB-OEG 
transplantation and another for tracer injection.  At the time of the last surgery, the 
animals were not only paraplegic but also aged (15 months old). Animal care protocols 
were adapted from those used for humans (27). 
 
Functional Analysis 
A detailed description of the climbing test used in this study was previously 
reported (4), is described in Appendix 1 and presented as Supplemental data (Video, 
Supplemental Digital Content 1, http://links.lww.com/NEN/A62). Training started when 
animals were 1 month old and continued until the first surgery.  Comparison of the 
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performance of transplanted and non-transplanted rats started 1 month after the first 
surgery (lesion) (Fig 2).  
 
Tracer injection 
At 12 months after lesion, all animals underwent a third surgery for tracer 
injection.  A cocktail of 25% Horseradish Peroxidase (HRP) and 5% wheat germ 
agglutinin (WGA)-HRP (Sigma-Aldrich Química, Madrid, Spain) in 0.9% NaCl was 
injected stereotaxically into the caudal stump, at 0.5 cm from its edge as before (3).  
Briefly, peroxidise was injected into 13 sites (0.1μl /site) ventrodorsally in the midline 
(5 injections) and at 0.8 mm to the left and right (4 injections in each side) at 2, 1.6, 1.2, 
0.8, and 0.4 mm in the midline; 1.6, 1.2, 0.8, 0.4 mm in left and right sides. Rats were 
allowed to survive 48 hours before perfusion.  This retrograde tracer is endocytosed by 
axons either passing through or terminating at the site of injection and hence, by axons 
regenerating at least 0.5 cm beyond the lesion. 
 
Histological processing 
Animals were perfused with 4% paraformaldehyde; the spinal cords and 
brainstems were dissected and post-fixed for 5 hours.  Coronal sections of the 
brainstems and longitudinal sagittal sections of the spinal cords were obtained in a 
cryostat (-20ºC, 20 μm sections). Consecutive sections of the whole structures were 
collected onto different slides and processed for peroxidise detection and 
immunohistochemistry. 
Peroxidase detection 
 We sectioned the entire brain stem (20 m sections) and collected all sections 
sequentially in order to locate each section within the brain stem.  For peroxidase 
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detection, equally spaced sections (100 m) were processed through the entire 
brainstem.  In these sections, the cytoplasms of Peroxidase-traced somata were detected 
with the chromogen diaminobenzidine (DAB, Vector Laboratories, Burlingame, CA).  
To increase the signal, sections were also labelled with an antibody against wheat germ 
agglutinin (anti-WGA, Vector, 1/250, overnight at 4ºC) and a biotinylated-conjugated 
secondary antibody (Vector Laboratories, Burlingame, CA) (1/200, 45 min), then 
incubated with Vectastain Elite ABC Kit Standard from Vector as indicated by 
manufacturer.  Spinal cord sections of 3 animals per group (n=9) were also processed as 
described above in order to determine whether peroxidase diffused beyond the injury 
region (Figure, Supplemental Digital Content 2, http://links.lww.com/NEN/A63) 
Immunohistochemical labelling of the spinal cord 
We labelled spinal cord sections containing the entire injury region and 2 
segments above and below (i.e. from T6 to T10).  Because the sections were collected 
sequentially, we could identify the precise location of each section within the cord.  
Depending on the type of analysis (see below), these sections were incubated overnight 
at 4ºC with the following primary antibodies: polyclonal rabbit anti-glial Fibrillary 
Acidic Protein (GFAP, Dako, Barcelona, Spain; 1/500) to label reactive astroglia and to 
delimit the glial scar; monoclonal mouse anti-Neurofilament (NFL, Hybridoma Bank 
RT 97, Iowa City, Iowa; 1/1500) to stain axons; and polyclonal rabbit anti-Rat S100 
(Dako, Barcelona, Spain; 1/100) to distinguish OEG.  The following day, sections were 
incubated with the respective secondary antibodies conjugated with Texas Red (Jackson 
Immunoresearch, West Grove, PA; 1/500) or Oregon Green (Molecular Probes- 
Invitrogen, Barcelona, Spain; 1/500), for 45 min at room temperature. Labeled sections 
were mounted with Fluoromount (SouthernBiotech, Birmingham, AL) and 
coverslipped. 
Muñoz-Quiles C, Santos-Benito FF, Llamusi MB and Ramón-Cueto A 
Journal of Neuropathology and Experimental Neurology, Dec 2009; Vol 68 (12); pp 1294-1308 
 
9
 
Quantification methods at the injury site 
Quantification of tissue degeneration  
 Every fifth section of the entire spinal cord separated by100 m was analysed 
(28 sections per rat). Fibrous scar and cavities, a direct consequence of tissue 
degeneration, are GFAP negative and were quantified by measuring the volume of 
GFAP-negative tissue at the injury site.  In each GFAP-labelled section we digitalized 
the lesion area using a Leica microscope.  In each section, fibrous scar and cystic areas 
(GFAP negative tissue) were outlined and measured (µm2) using the image analysis 
program Metamorph, and the volume calculated as previously described (28, 29).  
Briefly, individual “subvolumes”, which correspond to the area in 1 section multiplied 
by the distance to the next (100 µm), were summed. 
Quantification of axons 
Twenty eight sections adjacent to those used for the quantification of tissue 
degeneration (also separated 100 m) were double stained with anti-GFAP to define the 
borders of the GFAP positive glial scar and with anti-NFL to detect axons. 
Quantification was done within the GFAP negative fibrous scar. From the total number 
of pixels in this region determined by image analysis, the percentages of those showing 
anti-NFL labelling were calculated. The averages of the percentages per rat were used 
for group comparisons. We used the image analysis program Metamorph. 
Quantification of neuronal regeneration 
 Every fifth section of the whole brainstem was used for quantifying the number of 
peroxidase-traced neurons.  Because sections were collected in order, the precise 
location within the brain stem of each section was known.  For nuclei identification we 
followed Patxinos and Watson atlas (30).  A distance between sections of 100 m 
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avoided double/triple counting the same neuron in adjacent sections and, hence, false 
positive counts.  Peroxidase-containing somata were identified by the cytoplasmic 
brown DAB chromogen reaction.  We counted the total number of labelled cell bodies 
in the locus coeruleus, reticular formation, raphe, vestibular and red nucleus using a 
Leica microscope. Sections used for counting in each nucleus, and per rat, were the 
following: i) red nucleus: 14 (left) and 14 (right); ii) Reticular formation: 66; iii) locus 
coeruleus: 20 (left) and 20 (right); iv) vestibular nucleus: 26 (left) and 26 (right); v) 
raphe nucleus: 60. Images of sections were taken at 10x magnification using a camera 
(Leica DFC300 FX) attached to the microscope.  
 
Statistical Analysis 
 The variables of the behavioural recovery study were ordered categories (31).  
Each climbing grid was placed at an increasing angle from the horizontal plane and, 
thus, has a higher slope than the previous (45º<60º<75º<90º).  Each slope correlates 
with one level of difficulty for the animals.  We assigned scores to each ordinal category 
or slope and named them “climbing levels” (1<2<3<4).  For ordinal categories, non-
parametric Kruskal-Wallis and Mann-Withney U tests are most appropriate (32).  We 
used the former test to compare the ability of the non-T, OEG-transplanted and Sham 
groups to climb the 4 different climbing levels at both SA and Chr stages.  Post hoc 
“Conover-Inman was used for pairwise comparisons (33).  Mann-Whitney U test was 
used to compare the ability to succeed in the climbing test of non-T versus OEG-
transplanted groups, also at both, SA and Chr stages.  We also used Kruskal-Wallis to 
evaluate the significance of the time-dependent improvement in function observed 
within the same group and between groups.  Statistical analyses of differences between 
groups in the number of regenerated neurons (total and nuclei by nuclei) and the extent 
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of tissue degeneration at the injury site were also made by nonparametric Kruskal-
Wallis and Mann-Whitney tests.  Non-parametric statistics were used because the 
experimental groups had fewer than 10 animals.  Data are presented as the mean + 
SEM.  In all cases, differences were considered significant if p < 0.05. Linear regression 
analysis was used to evaluate the correlation between the functional recovery and the 
number of neurons regenerating axons from individual animals. 
 For an estimation of the temporary progression of the functional recovery per rat, a 
score for each animal was calculated by summing the level achieved in the climbing test 
at each month during the testing period. The scores obtained were also correlated by 
linear regression with the number of regenerated neurons from individual animals. 
 
RESULTS 
 All animals survived following injury and after the following 2 surgeries 
(transplantation and tracer injection), except for 1 Non-T rat that died during the second 
surgery (DMEM injection); 4 more Non-T rats died, respectively, at 1, 1.5, 2 and 4 
months after the second surgery because of autonomic dysreflexia or unknown causes. 
One Non-T rat was eliminated from the study because it developed autotomy of its hind 
limb. Thus, 6 rats were used as Non-T controls. Strikingly, none of the OB-OEG grafted 
rats presented any complication and just 1 animal from the Chr group died at the very 
end of the study (11.5 months after injury).   
 
OB-OEG-transplantation improved voluntary hindlimb movement 
All transplanted and non-T SCI animals presented flaccid hindlimb paralysis. 
We started to test the climbing ability of all animals 1 month after lesion.  During the 
whole period, Non-T rats of either group (second surgery after 1 or 4 months) did not 
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show any difference in the performance (p = 0.794 and p = 0.770, respectively).  This is 
in agreement with previous studies showing the absence of histological differences after 
culture medium injection (10). In addition, in our case, this indicates that the second 
surgery and our injection protocol were innocuous and did not interfere with the normal 
progression of the pathology.  Because all paraplegic Non-T rats were not statistically 
different, they were considered as a single group (n = 6). 
Rats from both SA and Chr groups behaved as Non-T rats in the climbing test 
before transplantation.  We started comparing the climbing behaviour of OB-OEG 
grafted and non-grafted rats from the first month post-grafting which corresponds to the 
second month post-lesion for the SA group and the fifth for the Chr (Fig. 3C). 
Functional recovery after grafting at the subacute stage 
All SA transplanted rats succeeded in performing the climbing test (fig 3A). 
There was a significant functional improvement of SA group in the ability to climb with 
respect to the non-T group (p < 0.001).  The OB-OEG grafted rats showed a progressive 
improvement in climbing abilities and from the second month after transplantation, 
differences between SA and Non-T rats became evident. At this time, 2 (40%) out of 5 
SA rats achieved level 1. A month later, one of these rats improved up to level 2, and a 
third reached level 1. At 5 months postgrafting, all SA rats succeeded in the climbing 
test: 1 achieved level 3 and 4 (80%) reached level 1. By comparison, half of Non-T rats 
(50%) failed to perform any climbing level.  Although the remaining exhibited some 
spontaneous improvement, the recovery of Non-T rats was never comparable with that 
of transplanted animals.  Only 1 of 6 Non-T rats overcame level 1 at the second month 
post-injury and was the only one improving thereafter. After the fourth and fifth 
months, respectively, another 2 rats achieved the lowest climbing level, but with no 
further improvement (Fig. 3A).  By comparison, SA animals presented better scores in 
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the climbing test, with statistical significance, and continued improving function after 
the fifth month. At 7 months after OB-OEG transplantation, SA rats reached their 
maximum functional recovery, 4 of them (80%) achieving level 3, and 1 level 2 (Fig. 
3A).  A monthly comparison of functional outcome showed significant differences 
between SA and Non-T groups from the sixth month after transplantation until the end 
of the experiment.  Conover-Inman post hoc values were p = 0.0145 at the sixth month 
and p = 0.0095 at the seventh month.  Mann-Whitney U test also showed a significance 
of p = 0.029 at month six and p = 0.020 at month seven and later.  After the fifth month 
post-grafting, the climbing performance exhibited by OB-OEG transplanted rats was 
better than at the first (p = 0.004) and second months (p = 0.042).  This time-dependent 
recovery was improved further at seventh month. Climbing performance at seventh 
month was significantly better than that at first (p = 0.004), second (p = 0.006) and third 
and fourth months (p = 0.009, both).  By comparison, Non-T animals did not improve 
their climbing abilities with time and the spontaneous outcome exhibited by some of 
them did not have statistical significance. 
Functional recovery after grafting at the chronic stage 
Before transplantation, Chr rats behaved in the climbing test similar to Non-T 
rats.  After transplantation (4 months after injury) they recovered function more than 
Non-T rats (p = 0.002).  One Non-T and 2 Chr rats showed some spontaneous recovery 
just before the second surgery (4 months post-lesion) by achieving the lowest climbing 
level (not shown).  The functional capabilities of the 2 Chr rats showing some recovery 
were not diminished after OB-OEG injection, suggesting a proper integration of the 
graft within the cord parenchyma and indicating that our transplantation can be 
performed safely after a chronic SCI. 
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The Chr rats improved motor function significantly more than Non-T rats 
(p=0.002) and improvement was progressive (p=0.016) (Fig. 3B). The Chr rats had 
improved motor function 2 months (6 post-lesion) after grafting.  At this period 3 rats 
achieved level 1 and, a month later, they had improved to level 2 or to level 3.  All Chr 
rats were able to climb at least level 1 at 4 months after grafting.  At the fifth month, 3 
out of 5 rats were able to achieve level 3, 1 achieved level 2, and the other level 1.  
These animals gained their maximum functional recovery after the seventh month and 
this was significantly different from the maximum climbing performance achieved by 
Non-T rats (Conover-Inman p = 0.0299, Mann-Whitney U test p = 0.045).  The level of 
recovery of the Chr rats observed was statistically higher at 4 months post-grafting than 
at 1 (p = 0.021) and 2 months (p = 0.033).  These differences remained significant and 
increased further at the seventh month (p = 0.013 vs month 1; p = 0.016 vs month 2) 
(Fig. 3C). 
 Comparison between OB-OEG-transplanted groups at subacute and chronic 
stages 
Despite the transplantation delay (1 or 4 months), SA and Chr rats started 
recovering motor function after the second month post-grafting and continued doing so 
during the following months. There were no differences in climbing performance at any 
month post grafting (p between 0.1 and 0.635) reaching the maximum at seventh month. 
All OB-OEG transplanted rats presented movement of the hindlimbs, plantar placement 
of the paws and body weight support, necessary to succeed in the test, independent of 
the stage of transplantation (n = 10). At the end of the study, regardless of the 
transplantation delay, 70% of all OEG grafted rats were able to reach the platform by 
climbing from level 3, 10% climbing from the level 2 and 20% from level 1. All (100%) 
rats from SA and Chr groups had accomplish the climbing test by the fifth and fourth 
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months respectively. At these post-grafting testing periods the climbing performance 
significantly exceeded the previous test period (p = 0.004 and p = 0.021 respectively).  
 
Tissue repair after SCI by OB-OEG grafts 
Evaluation of transplantation effects on scarring 
Macroscopically, in all transplanted rats there was a white and opaque tissue at 
the injury site bridging both cord stumps (Fig. 4A and B), suggesting some quantitative 
differences in the tissue. This property was not observed in Non-T animals. Instead, the 
bridge region appeared thin and translucent (Fig. 4C).  By microscopy, all injured spinal 
cords showed an interruption of GFAP immunolabelling at the lesion, over the entire 
spinal cord width, indicating that transection was complete (Fig. 5).   
The Hoechst dye was not transferred from OB-OEG to cells of the host spinal 
cords (Appendix 2; Figure, Supplemental Digital Content 3, 
http://links.lww.com/NENA64). The distribution of OB-OEG within the spinal cord 
was the same as previously described after transplantation at the acute stage (3, 4). 
Briefly, OB-OEG migrated from the injection sites and invaded the glial and fibrous 
scars. They intermingled with reactive astrocytes and the inhibitory fibrous scar did not 
hinder their migration Figure, Supplemental Digital Content 3, 
http://links.lww.com/NENA64).  To quantify the effect of OB-OEG on tissue repair and 
scarring, we calculated the volume of GFAP-negative tissue (fibrous scar) and cavities 
formed between GFAP positive stumps (Fig. 5).  Both volumes (fibrous scar and 
cavities) were added together as they provide a measure of trauma-induced degeneration 
(see methods).  The mean volume of GFAP negative tissue was larger in Non-T group 
(4.93 ± 0.96 mm3) as compared with SA (2.42 ± 0.34 mm3, p = 0.009) and Chr (2.14 ± 
0.57 mm3, p = 0.05 for Chr) groups (Fig. 5). Therefore, the amount of fibrosis and 
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necrosis was double in non-grafted spinal cords with respect to OB-OEG containing 
ones.  This indicates that OB-OEG favoured either the formation of new tissue and 
better stump healing and/or the decrease of tissue loss in the case of SA rats, thereby 
helping spinal cord repair at the lesion site.  There were not significant differences in the 
values between rats transplanted at SA and Chr stages (p = 0.624).  Thus, the efficacy of 
OB-OEG in spinal cord preservation at the injury appears to be maintained 
independently of the timing of transplantation.  The volume of GFAP negative tissue 
(fibrosis and cysts) was inversely related to the maximum functional levels in the 
climbing test (r = -0.800; p < 0.001).  Therefore, better tissue preservation in OB-OEG 
grafted rats seemed to help axonal regeneration across the lesion. 
 
OB-OEG promotes axonal regeneration of brainstem neurons beyond the scar 
Axons unable to cross tend to sprout more profusely in the scar than axons 
elongating straight beyond. Consequently, nontreated animals may have more fibers 
within the scar than animals showing axonal regeneration.  Although this makes NFL 
labeling at the scar not a very accurate method for quantification of axonal regeneration, 
we wanted to have an estimation of the number of fibers invading the injury region.  We 
observed NFL-immunolabeled axons entering the scars in both OB-OEG grafted and 
Non-T spinal cords. There were no group differences in the number of pixels 
representing NFL positive sprouts within the scar tissue of SA, Chr and Non-T rats (p = 
0.462). 
To quantify axonal regeneration beyond the lesion, we injected the retrograde 
tracer at 0.5 cm from the rostral border of the caudal stump.  We observed no 
inadvertent leakage or spread of the tracer rostrally into the lesion, by analysing 
microscopically the spinal cords of 3 animals from each group.  The retrograde tracer 
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did not reach the injury site or the edge of the caudal stump, but instead remained within 
the caudal cord Figure, Supplemental Digital Content 2, 
http://links.lww.com/NENA63).  Because the tracer was injected at 0.5 from the lesion, 
only axons crossing the injury region, invading the caudal stump and growing at least 
0.5 cm beyond could pick up the tracer Thus, all neurons containing peroxidase were 
regenerating neurons whose axons grew 0.5 cm or more far down into the caudal stump. 
Retrogradely peroxidase-labelled neurons were counted in 5 brainstem nuclei relevant 
for the initiation and modulation of locomotor patterns: reticular formation, locus 
coeruleus, vestibular, raphe and red nucleus. All nuclei examined contained HRP-
labelled neurons (Fig. 6). The mean total number of peroxidase-labelled neurons in the 
brainstem of sham rats was 16,399 ± 609 (n = 3). This value was 5,203 ± 1,116 in SA 
rats and 6,330 ± 1,176 in Chr group. The total number of neurons regenerating their 
axons beyond the lesion was more than twice in OB-OEG grafted animals (either SA or 
Chr) compared to Non-T rats (2,198 ± 416) and this was statistically significant (p < 
0.018) (Fig. 7).  Significance was greater when analysis was performed comparing 
individual nuclei: Reticular formation (SA: p = 0.006; Chr: p = 0.011), vestibular 
nucleus (SA: p = 0.018; Chr: p = 0.019), locus coeruleus (SA: p = 0.018; Chr: p = 
0.033), red nucleus (SA: p = 0.018; Chr: p = 0.011) and raphe (SA: p = 0.201; Chr. p = 
0.019).  The only exception was raphe nucleus of the SA group, in which differences 
were not significant. The Chr rats exhibited greater numbers of regenerating brainstem 
neurons in all analysed nuclei than SA rats, but differences between the transplantation 
paradigms were not significant.  The percentage of total traced neurons, per nuclei and 
experimental group, with respect to equivalent nuclei of sham animals (100 %) was 
38.6% and 31.7% in Chr and SA, respectively.  By comparison 13.4% of neurons of the 
Non-T rats were labeled.  Raphe and red nuclei contained the highest number of 
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regenerating neurons in both SA and Chr groups. The SA rats presented 63.4% and 
46.6% of neurons traced in raphe and red nuclei respectively, and the Chr rats showed 
58.2% and 46.9%. Interestingly, in Non-T animals, the raphe and red nuclei showed 
more spontaneous regeneration than other nuclei with 25.9% neurons labelled in raphe 
and 28.9% in the latter. The highest incidence of regenerating neurons after OB-OEG 
grafting (up to eight fold) was observed in the locus coeruleus (19% in Chr; 13.8% in 
SA, compared to 2.4% in Non-T). The percentage of peroxidase-labelled neurons in the 
reticular formation and vestibular nuclei of transplanted rats compared to sham animals 
was 30 to 40 %, respectively; three times more than in Non-T group (Table). 
In summary, the histological results show that axons from several brainstem nuclei 
that arer relevant to motor function were able to cross the scars and grow beyond into 
the caudal stump.  The extent of axonal regeneration was similar in rats transplanted at 
SA and Chr phases, indicating that the repair efficacy of OB-OEG remained unaltered 
after delayed transplantation and was independent of the stage of the healing process. 
Moreover, brainstem neurons retained their capacity to respond positively to OB-OEG 
up to 4 months post-lesion.  Therefore, there is a window of at least 4 months in which 
OB-OEG could be applied without any apparent adverse effect. 
 
Functional outcome correlated with the extent of axonal regeneration and tissue 
preservation. 
The maximum climbing level achieved by each rat was positive correlated with 
total number of retrogradely labeled brainstem neurons (r = 0.733; p = 0.001).  There 
was also a correlation between climbing ability and the number of somata in each 
independent nucleus and in all nuclei analyzed (r = coefficients ranging from 0.784 - 
0.641; p < 0.008). To estimate the temporary progression of functional recovery per rat, 
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a score was obtained per animal by summing the level achieved each month during 8 
months posttransplantation.  We selected this period because there was no further 
improvement after the seventh month.  The final score obtained for each rat in the 
performance in the climbing test correlated with both the total number of labeled cell 
bodies (r = 0.897; p < 0.001) and the number of somata in each nucleus (r = 0.899-
0.847; p < 0.001).  These positive linear correlations are consistent with the concept that 
these brainstem neurons contributed to the functional improvement of the implanted 
rats. In addition, there was a linear negative correlation between the volume of GFAP-
negative tissue (fibrosis and cavities) and the total number of traced brainstem neurons 
in both, all (r =-0.767 p < 0.001) and each (r = 0.780-0.697; p < 0.002) nuclei. This 
indicates that the smaller the degenerative events at the injury site, the greater axonal 
regeneration across.  Therefore, our results suggest a role of OB-OEG on tissue 
preservation and/or tissue formation at the lesion zone that may facilitate axonal 
regeneration across.  
 
DISCUSSION 
 The OB-OEG promoted both functional recovery of paraplegic rats and 
regeneration of supraspinal axons caudal to the lesion in rats receiving a graft after 1 
and 4 months after the complete lesion. Strikingly, functional outcome after OB-OEG 
transplantation at 4 months post-lesion did not differ from that at either SA or acute (4) 
time points. In addition, axonal regeneration of brainstem neurons, involved in different 
aspects of motor function (34), was more than twice in OB-OEG-transplanted versus 
nontransplanted rats, again, with no differences related to time posttransplantation.  
Finally, the positive correlation between locomotor performance and extent of axonal 
regeneration distally is consistent with those brainstem neurons having contributed to 
the motor recovery (35-37).  Thus, our results show that the effectiveness of adult OB-
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OEG and tissue repair was not affected by the stage of the scarring processes, and that 
injured neurons preserved their capacity to positively respond to OB-OEG for at least 4 
months. 
 The beneficial effects of OB-OEG have been related to enhanced axonal 
regeneration, survival and tissue sparing, remyelination, stimulation of angiogenesis and 
neuroprotection (38-41). Moreover, a recent report revealed that OB-OEG express key 
molecules involved in the response to wounding, blood vessel development, 
extracellular matrix formation and remodelling, and cell adhesion (42). Based on the 
present results, therefore, OB-OEG transplantation at subacute and chronic SCI stages 
could be exerting a reparative action via any or all of the mechanisms; remyelination 
was not examined in this study, however. 
Our study constitutes the first evidence showing that chronic SCI can be repaired 
by OEG transplants. Lu  et al (19) and Lopez-Vales et al (20) performed transplantation 
at the subacute stage, that is, after 30 and 45days, respectively.  Moreover, we used 
adult OB-OEG (central), whereas in the former OEG were obtained from lamina propria 
(peripheral) and in the latter study, from neonatal bulbs. It has been reported that 
mucosal OEG do not exhibit the same migratory or axonal growth-promoting properties 
as bulbar OEG in rodents (16-18) and neonatal OEG do not exhibit the same properties 
as adult (24-43).  The observation that implantation of adult OEG can improve recovery 
after spinal cord injury and a decrease in efficacy when used in a chronic stage makes 
this a more realistic paradigm for autologous cell therapy for chronic SCI. 
In the context of a possible future clinical application, it has been demonstrated 
that OEG can be obtained from the OBsof adult humans (44) and non-human primates 
(11). These cells can be easily cultured in standard incubators and expanded in large 
numbers just using serum-containing medium.  A culture of one single primate olfactory 
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bulb provides, in a short term (ten days in vitro), around 1.5-2 million OEG, and 
additional 20 billion cells after 2.5 months.  This large number guarantees not only 
autologous transplantation but also provides cells for allotransplantation and storage.  
These cells express similar axonal-growth related molecules as rodent cells in vitro (11, 
44)  A key issue in this regard is the demonstration that primate OB-OEG from healthy 
donors ranging in age from 1.5 to 10 years (young to mature adult), promoted 
locomotor recovery after transplantation into paraplegic rodents (45).  The surgical 
procedures that are compatible with human practice for unilateral bulbectomy and for 
autologous transplantation into injured spinal cords have been determined and checked 
for safety in non-human primates (11, 27).  Therefore, these data point to the OB as a 
reliable source of OEG for cell therapy. 
 A remaining and important issue addressed in the present study was the feasibility 
of OB-OEG autologous grafting for spinal cord repair.  The most probable clinical 
scenario is of a young adult or adult patient who requires stabilization of the clinical 
condition after accident. Hence, it seems safer to perform bulbectomy some time after 
injury.  Moreover, after bulb removal, cells need to be grown for at least 10 days in 
order to obtain enough OEG for transplantation.  Accordingly, the experimental 
condition that would mimic the clinical situation more closely is the implantation in the 
chronic situation of OEG obtained from adults. We show that adult OB-OEG can 
effectively promote functional recovery and repair in paraplegic mammals when they 
are transplanted at chronic stages.  Grafting can be delayed for, at least, a period of 4 
months postlesion with no decrease in beneficial effects.  In the case of an autologous 
therapy, this window would seem to provide enough time to obtain and prepare OEG 
from the olfactory bulbs and also for patient stabilization before the surgery.  Therefore, 
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our results open the prospect for a future therapy with autologous implanted OB-OEG 
in patients experiencing a severe chronic SCI. 
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Appendix 1 
 
Climbing Test 
For this test, a rat has to climb from a grid of 25 x 25-mm2 holes and completely 
pass its body onto a smooth horizontal platform located at a height of 70 cm. The 
platform is smooth and slippery so the animals cannot cross it using their forelimbs. An 
animal can only succeed if it voluntarily moves its hindlimbs, properly placing the paws 
on the rungs and pushing its body upward (Video, Supplemental Digital Content 1, 
http://links.lww.com/NEN/A62). The test has 4 difficulty levels (i.e. 1-4) depending on 
the slope of the grid (45, 60, 75, or 90 degrees, respectively). The higher the slope, the 
greater body weight support. Normal uninjured rats (and shams) achieve the highest 
level. To motivate the animals, they were rewarded with chocolate-hazelnut cream after 
each good performance. All animals were within a similar range of weight (270-300 g) 
for comparisons. Each animal was allowed 10 attempts per session. An attempt was 
counted when the rats pushed with their forelimbs and propelled the head above the 
horizontal platform. To keep animals unable to achieve the test motivated, a grid with 1 
x 1-cm squares on top of the smooth platform was placed only after several 
unsuccessful tries. Using this grid, animals could pull with the forelimbs upward, 
complete the performance, and receive the reward (Video, Supplemental Digital 
Content 1, http://links.lww.com/NEN/A62). We only considered a positive result when 
a rat achieved a specific level during 3 different weeks. Three examiners blinded to the 
treatment evaluated the outcome at the time of testing and by reviewing the videotapes 
of the sessions. 
Video sequences of the last part of the performances of representative Non-T 
rats and OB-OEG-grafted rats (SA and Chr) are shown (Video, Supplemental Digital 
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Content 1, http://links.lww.com/NEN/A62). The first video sequence is an example of a 
Non-T rat trying to achieve the lowest climbing level. This rat was unable to use its 
hindlimbs voluntarily and could not propel the body onto the smooth horizontal 
platform. A surface with a grid was placed on top of the platform so the animal could 
reach the top and be rewarded after unsuccessful attempts. The second video sequence 
shows an OB-OEG-transplanted rat achieving Level 1 at 4 months after grafting. This 
animal improved later on and achieved higher climbing levels. The third sequence 
shows an OB-OEG-grafted rat accomplishing the maximum level reached, that is, Level 
3. The 3 sequences are shown in slow motion to demonstrate hindlimb voluntary 
movements in transplanted rats compared with their absence in the Non-T animal. 
 
Appendix 2 
 
Tracking and Distribution of Grafted OB Ensheathing Glia After Transplantation 
There are no good markers for long-term detection of OB-OEG. Most of the 
immunocytochemical markers used for OEG detection in vitro may cause misleading 
results in vivo because they also label other cells. For example, anti-p75 antibody does 
not discriminate between grafted OEG and endogenous Schwann cells invading the 
lesion (7, 46). Transduction of OEG by adenoviruses or lentiviruses encoding tag 
molecules could be used to track transplanted OEG, but genetic manipulation of the 
cells may change their phenotype.  For long-term transplantation studies, the expression 
of genetic markers should be stable for the entire survival period, and the tag molecule 
should be nontoxic. Green fluorescent protein has been used in shorter-term 
transplantation studies to identify OB-OEG, but stable expression occurs only for up to 
4 months (1); thus, it is inappropriate for our experimental paradigm. Moreover, other 
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studies report toxic effects of green fluorescent protein on some cell types (47-49); 
some of these were not evident in culture but appeared after transplantation (50). 
In view of these data and our need to track the fate of OB-OEG 8 months after 
transplantation, we labeled the cells with bisbenzimide (Hoechst 33342; Sigma-Aldrich 
Química), as in our previous studies (3, 4). To our knowledge, this is the only vital dye 
that lasts 8 months after transplantation and has no toxic effects on OB-OEG. To be 
certain that the dye was not transferred from OEG to other cells, we determined whether 
the dye was present in macrophages immunostained with the anti-CD68 antibody ED1 
(Serotec MCA341R; 1:100) in the lesion sites of transplanted rats by confocal 
microscopy. The same sections were labeled with either anti-GFAP to delimit glial and 
fibrous scars (51, 52) or anti-S100 to detect OB-OEG (24). This analysis was performed 
on 10% of all spinal cord sections that were equally separated by 200 Km from 4 
transplanted rats, using a Leica confocal microscope (DM IRE2). 
The GFAP immunohistochemistry delimits glial and fibrous scars created at the 
injury site (Figure, Supplemental Digital Content 3, http://links.lww.com/NEN/A64, 
part A). We detected numerous Hoechst-labeled cells at both fibrous and glial scars 
(Figure, Supplemental Digital Content 3, http://links.lww.com/NEN/A64, parts A and 
B). There were few ED1-positive macrophages that were mainly located at the glial scar 
and borders of the fibrous scar (Figure, Supplemental Digital Content 3, 
http://links.lww.com/NEN/A64, parts A and C). If leakage of bisbenzimide had 
occurred from prelabeled OB-OEG, macrophages should have had blue nuclei, but we 
did not observe colocalization of ED1 and Hoechst dye within the same cells, indicating 
that the dye was not transferred to phagocytic cells (Figure, Supplemental Digital 
Content 3, http://links.lww.com/NEN/A64, parts B-D). Hence, if the dye had not been 
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phagocytosed by macrophages, it is very unlikely that it was transferred fromOB-OEG 
to other cells that lack active phagocytic activity. 
Fibrous scars created after SCI are formed by fibroblasts and are devoid of 
astrocytes; hence, they are GFAP and S100 negative (51, 52) (Figure, Supplemental 
Digital 
Content 3, http://links.lww.com/NEN/A64, part A). The OBOEG express S100 (24), 
and an antibody against this molecule can be used to identify OB-OEG in the fibrous 
scars of transplanted cords. S100-positive OB-OEG were found within the fibrous scar 
(Figure, Supplemental Digital Content 3, http://links.lww.com/NEN/A64, part E), and 
Hoechst-labeling colocalized with them (Figure, Supplemental Digital Content 3, 
http://links.lww.com/NEN/A64, part F).  The absence of Hoechst uptake by 
macrophages and the identification of this marker in OB-OEG indicate that under our 
experimental conditions, OB-OEG can be identified by their Hoechst nuclear staining. 
Hoechst-labeled OB-OEG migrated from the injection sites and invaded the glial 
scars at both rostral and caudal stumps, and also the fibrous scar. They intermingled 
with reactive astrocytes and the inhibitory environment of the fibrous scar tissue did not 
hinder their migration (Figure, Supplemental Digital Content 3, 
http://links.lww.com/NEN/A64, parts A and B). Some OB-OEG could also be found at 
the rostral and caudal spinal cord stumps. The OB-OEG seemed to properly integrate 
within the host parenchyma because there was neither swelling of the tissue, phagocytic 
cells around grafted OB-OEG, nor tissue disruption at the sites of injection that would 
suggest graft rejection. The histological appearance of the stumps was indistinguishable 
from that of sham control cords. 
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FIGURE 1 
 
 
 
Figure 1. Appearance of the surgical field during different phases of the 
procedure. A.  After transection, both spinal cord stumps were lifted to ensure 
completeness of the lesion. B. Spinal cord stumps were placed back into the vertebral 
channel, apposing one another. C-F shows the aspect of the lesion region during the 
second surgery (access to the spinal cord for transplantation). C. We first found the 
resin bridge (arrow) firmly sealed to the spinous processes and laminae of adjacent 
intact vertebrae. D.  After bridge removal, we found a dense layer of connective tissue 
that was removed (arrowheads) to expose the spinal cord underneath (arrow). E.  Dorsal 
aspect of both spinal cord stumps, four months after complete transection.  F. 
Transplantation of OB-OEG using a glass micro-needle (pointed by an arrow). Inbox 
shows a detail of an OB-OEG culture used for transplantation and immunolabelled 
against p75.  Arrow in A, B and E points to the spinal cord transection site. 
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FIGURE 2 
 
 
 
Figure 2. Video frames showing a paraplegic rat transplanted with OB-OEG at the 
chronic stage, achieving the third climbing level, five months after transplantation. 
We show a detail of the hind limb movement of this rat supporting its weight, and 
propelling the body to reach the horizontal platform.  The video of this animal is 
provided as Supplemental data file 2. 
FIGURE 3 
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Figure 3. Functional recovery of paraplegic rats after OB-OEG transplantation at 
subacute (SA) and chronic (Chr) stages. A, B. Levels achieved in the climbing test by 
(A) non-transplanted (Non-T) and SA, and by (B) Non-T and Chr rats, at 3, 5 and 7 
months post-grafting. 
Transplanted rats showed a functional recovery significantly higher than Non-T (SA: p 
< 0.001 and Chr: p = 0.001). Differences started to be significant from month six in SA 
rats (month 6: p = 0.029, month 7 and 8: p = 0.020), and from month seven in Chr (p = 
0.045). There were no differences between SA and Chr groups (compare A and B).  C.  
Progression of the functional outcome in all groups from the first month post-lesion 
until the end of the survival period (month twelve). Each point represents the percentage 
of functional recovery exhibited by animals of each group. Dashed lines show the 
periods we used to compare the outcome of Non-T versus SA (long dash) and Non-T 
versus Chr animals (short dash) from the first till the eighth month post-grafting. Non-T 
animals (grey rhombs) showed a slight but not significant recovery.  Before grafting, 
Chr and SA groups behaved as Non-T animals.  SA group (black circles) and Chr (black 
triangles) started improving two months after OB-OEG transplantation (three and six 
months post-lesion, respectively).  Improvement of SA and Chr rats commenced at the 
second month, and began to be significant from the fifth (p=0.004) and four months 
(p=0.021) respectively. 
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FIGURE 4 
 
 
 
Figure 4. Aspect of the transection site of OB-OEG-grafted and non-transplanted 
spinal cords, twelve months after lesion. Representative macroscopic images of spinal 
cords from (A) SA and (B) Chr OB-OEG transplanted rats, and from (C) one Non-T  
rat.  In all transplanted spinal cords (SA and Chr), rostral and caudal stumps were 
bridged by a white and opaque tissue (A and B), whereas in Non-T rats cord stumps 
were joined by a translucent membrane (C). 
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FIGURE 5 
 
 
 
Figure 5. Longitudinal spinal cord sections showing the areas used for 
quantification of GFAP negative tissue at the injury site.  Sections of Non-T (A) and 
OB-OEG-transplanted (B) spinal cords, immunolabelled with anti-GFAP.  Encircled 
lines represent both, GFAP negative fibrous scar (pointed by arrows) and cysts (without 
arrows).  The width of the cords for each individual animal was also measured in the 
sections (horizontal lines in A and B). Top: rostral; bottom: caudal. 
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FIGURE 6 
 
 
Figure 6. Brainstem coronal sections showing peroxidase-traced neurons in OB-
OEG-transplanted (A, C, E, G, I) and non-transplanted (B, D, F, H, J) rats.  A, B, 
reticular formation (RF).  C, D, vestibular nucleus (VN).  E, F, locus coeruleus (LC).  
G, H, raphe (R). I, J, red nucleus (RN). Panels on the left show sections from OB-OEG 
transplanted rats and those on the right correspond to Non-T rats. Scale bar A-J = 50 
μm. Top: dorsal; bottom: ventral.  
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FIGURE 7 
 
 
Figure 7. Quantification of neurons regenerating axons beyond the injury region. 
A-E. Histograms show the number of peroxidase-traced neurons in Non-T, SA, Chr and 
Sham groups counted in raphe (A), reticular formation (B), vestibular nuclei (C), locus 
coeruleus (D), red nuclei (E), and in all nuclei (F).  Black rhombs represent the number 
of cell bodies per animal and bars the average of cell bodies per group. The total 
number of traced neurons was significantly higher in SA and Chr animals than in Non-
T, and also when comparing per nuclei (except for raphe in SA rats) (p < 0.05). There 
were not significant differences between SA and Chr groups in any case.  
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TABLE 
 
 
 
Table 1. Number of peroxidase-containing neurons in the brainstems of Sham, SA, 
Chr and Non-T animals. Data are presented as mean ± SEM. This table also shows the 
percentage of labeled neurons per nuclei and per group.  We considered as 100% the 
average of labeled neurons in sham animals. 
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SUPPLEMENTAL DIGITAL CONTENT 1 
 
Figure Legend_Supplemental Data File 1_Movie file.  
We show some video sequences of the last part of the performances of representative 
Non-T rats and OB-OEG grafted rats (SA and Chr). The first sequence of this movie is 
an example of a Non-T rat trying to achieve the lowest climbing level.  This rat was 
unable to voluntary use its hindlimbs and could not propel the body onto the smooth 
horizontal platform. To avoid demotivation of animals unable to climb (such as Non-T 
rats), and only after several tries, a gridded surface was placed on top of the platform, so 
the animals can reach the top and be rewarded.  But this was never done unless animals 
made tries. 
The second video sequence shows an example of one OB-OEG-transplanted rat 
achieving level 1, four months after grafting.  Details of hindlimb movement and how 
the animal placed the paws on the rungs can be seen in slow motion. This animal 
improved later on and achieved higher climbing levels. The third sequence shows one 
OB-OEG-grafted rat accomplishing the maximum level reached: level 3. All three 
sequences are shown in slow motion to better visualize hindlimb voluntary movement 
of transplanted rats compared to the absence of this Non-T animals. 
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SUPPLEMENTAL DIGITAL CONTENT 2 
 
 
 
Figure Legend_Supplemental Data File 2_Figure.  
Tracer did not diffuse from the injection site into the injury region and remained beyond 
within the caudal spinal cord stump. All three pictures show the same field of the caudal 
spinal cord stump, visualized using (A) bright field, (B) phase contrast, and dark field 
(inbox in A). Arrows point to tracer location in the caudal spinal cord stump. Dashed 
lines delimit the caudal border of the injury. Notice that the tracer remained within the 
caudal stump and did not invade the injury region. 
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SUPPLEMENTAL DIGITAL CONTENT 3 
 
 
 
Figure Legend Appendix 2 
Confocal microscopy images of the spinal cord injury region eight months after OB-
OEG transplantation at chronic stage.  Final images are the merge of the confocal 
images (stacks) obtained from each whole section.  A-D show the same filed of a 
section immunostained with anti-GFAP and ED1.  E-F panels represent an adjacent 
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section to that shown in A-D, immunostained against S100 and ED1. A, GFAP positive 
immunoreactivity delimits the glial and the fibrous scars. B, Visualization of Hoechst 
labeled OB-OEG in the same section shown in A.  C, Immunostaining of macrophages 
and microglia in the same section using anti-ED1 antibody. D, Merge of B and C.  ED1 
positive macrophages (green) were not labelled with Hoechst (blue). E shows S100 
positive cells in the fibrous scar (compare A and E).  F. Cells stained with anti-S100 
(red), anti-ED1 (green) and Hoechst (blue).  Notice in the fibrous scar the presence of 
cells expressing S100 and labeled with Hoechst. White line in all the figures encircles 
the fibrous scar.  Scale bar in all figures= 150 m. 
 
 
 
